These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Patient-derived xenograft models for personalized medicine in colorectal cancer. Xie J; Lin Y Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151 [TBL] [Abstract][Full Text] [Related]
10. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance. Shi J; Li Y; Jia R; Fan X Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514 [TBL] [Abstract][Full Text] [Related]
11. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Izumchenko E; Paz K; Ciznadija D; Sloma I; Katz A; Vasquez-Dunddel D; Ben-Zvi I; Stebbing J; McGuire W; Harris W; Maki R; Gaya A; Bedi A; Zacharoulis S; Ravi R; Wexler LH; Hoque MO; Rodriguez-Galindo C; Pass H; Peled N; Davies A; Morris R; Hidalgo M; Sidransky D Ann Oncol; 2017 Oct; 28(10):2595-2605. PubMed ID: 28945830 [TBL] [Abstract][Full Text] [Related]
12. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics. Liu JF; Palakurthi S; Zeng Q; Zhou S; Ivanova E; Huang W; Zervantonakis IK; Selfors LM; Shen Y; Pritchard CC; Zheng M; Adleff V; Papp E; Piao H; Novak M; Fotheringham S; Wulf GM; English J; Kirschmeier PT; Velculescu VE; Paweletz C; Mills GB; Livingston DM; Brugge JS; Matulonis UA; Drapkin R Clin Cancer Res; 2017 Mar; 23(5):1263-1273. PubMed ID: 27573169 [No Abstract] [Full Text] [Related]
14. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models. Okada S; Vaeteewoottacharn K; Kariya R Cells; 2019 Aug; 8(8):. PubMed ID: 31412684 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model. Luo M; He Y; Xie B; Li S; Gan F; Zhang S; Luo P Pediatr Surg Int; 2021 Aug; 37(8):1031-1040. PubMed ID: 34031745 [TBL] [Abstract][Full Text] [Related]
16. Development and Application of Genetic Ancestry Reconstruction Methods to Study Diversity of Patient-Derived Models in the NCI PDXNet Consortium. Lott PC; Chiu K; Quino JE; Vang AP; Lloyd MW; Srivastava A; Chuang JH; ; Carvajal-Carmona LG Cancer Res Commun; 2024 Aug; 4(8):2147-2152. PubMed ID: 39056190 [TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine. Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364 [TBL] [Abstract][Full Text] [Related]
18. Patient-derived xenografts as in vivo models for research in urological malignancies. Inoue T; Terada N; Kobayashi T; Ogawa O Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952 [TBL] [Abstract][Full Text] [Related]
19. Of Mice and Melanoma: PDX System for Modeling Personalized Medicine. Hartsough EJ; Aplin AE Clin Cancer Res; 2016 Apr; 22(7):1550-2. PubMed ID: 26842234 [TBL] [Abstract][Full Text] [Related]
20. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research. Jung J; Seol HS; Chang S Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]